News
Trade your diet soda for a tall glass of water, a new small-scale study argues. Women were more likely to drop pounds and see ...
CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...
CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...
1d
MedPage Today on MSNOnce-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 DiabetesA once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III ...
BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene ...
Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...
Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results